Role of leukotrienes in the regulation of human granulocyte behaviour: Dissociation between agonist-induced activation and retardation of apoptosis

British Journal of Pharmacology

Volumn 139, Issue 2, 2003, Pages 388-398

  Murray, Joanna ^a   Ward, Carol ^a   O'Flaherty, Joseph T ^b   Dransfield, Ian ^a   Haslett, Christopher ^a   Chilvers, Edwin R ^c   Rossi, Adriano G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Calcium; Eosinophils; Leukotrienes; Neutrophils

Indexed keywords

1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; BUCLADESINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; MONTELUKAST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CALCIUM CELL LEVEL; CELL FUNCTION; CELL POLARITY; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; EOSINOPHIL; GRANULOCYTE; HUMAN; HUMAN CELL; MEDIATOR; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM;

ACETATES; ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; BENZOPYRANS; CALCIUM; CARBOXYLIC ACIDS; CELL SURVIVAL; CELLS, CULTURED; EOSINOPHILS; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; LEUKOTRIENE D4; NEUTROPHILS; QUINOLINES;

EID: 0038606743     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705265     Document Type: Article

References (52)

1. BLAYLOCK, M.G., CUTHBERTSON, B.H., GALLEY, H.F., FERGUSON, N.R. & WEBSTER, N.R. (1998). The effect of nitric oxide and peroxynitrite on apoptosis in human polymorphonuclear leukocytes. Free Radic. Biol. Med, 25, 748-752.
2. CHINETTI, G., GRIGLIO, S., ANTONUCCI, M., TORRA, I.P., DELERIVE, P., MAJD, Z., FRUCHART, J.C., CHAPMAN, J., NAJIB, J. & STAELS, B. (1998). Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem., 273, 25573-25580.
3. COLOTTA, F., RE, F., POLENTARUTTI, N., SOZZANI, S. & MANTOVANI, A. (1992). Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood, 80, 2012-2020.
4. DAHINDEN, C.A., ZINGG, J., MALY, F.E. & DE WECK, A.L. (1988). Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component CSA and FMLP as second signals. J. Exp. Med., 167, 1281-1295.
5. 4 pathway to inflammation control. Nature, 384, 39-43.
6. 2, and PAF. J. Clin. Invest., 101, 890-898.
7. FORD-HUTCHINSON, A.W., BRAY, M.A., DOIG, M.V., SHIPLEY, M.E. & SMITH, M.J. (1980). Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature, 286, 264-265.
8. FORTENBERRY, J.D., OWENS, M.L., BROWN, M.R., ATKINSON, D. & BROWN, L.A. (1998). Exogenous nitric oxide enhances neutrophil cell death and DNA fragmentation. Am. J. Respir. Cell. Mol. Biol., 18, 421-428.
9. FUJIHARA, S., WARD, C., DRANSFIELD, I., HAY, R.T., UINGS, I.J., HAYES, B., FARROW, S.N., HASLETT, C. & ROSSI, A.G. (2002). Inhibition of nuclear factor-κB activation un-masks the ability of TNF-α to induce human eosinophil apoptosis. Eur. J. Immunol., 32, 457-466.
10. GIEMBYCZ, M.A. & LINDSAY M.A. (1999). Pharmacology of the eosinophil. Pharmacol. Rev., 51, 213-340.
11. GOMPERTZ, S. & STOCKLEY, R.A. (2000). Inflammation - role of the neutrophil and the eosinophil. Semin. Respir. Infect., 15, 14-23.
12. HASLETT, C. (1999). Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med., 160, S5-S11.
13. HEBERT, M-J., TAKANO, T., HOLTHÖFER, H. & BRADY, H.R. (1996). Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. J. Immunol., 157, 3105-3115.
14. 4 receptor. J. Biol. Chem., 275, 27000-27004.
15. KITCHEN, E., ROSSI, A.G., CONDLIFFE, A.M., HASLETT, C. & CHILVERS, E.R. (1996). Demonstration of reversible priming of human neutrophils using platelet-activating factor. Blood, 88, 4330-4337.
16. LAWRENCE, T., WILLOUGHBY, D.A. & GILROY, D.W. (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol., 2, 787-795.
17. LEE, A., WHYTE, M.K.B. & HASLETT, C. (1993). Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol., 54, 283-288.
18. 4 receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors. Am. J. Respir. Crit. Care Med., 160, 2079-2085.
19. LEE, E., ROBERTSON, T., SMITH, J. & KILFEATHER, S. (2000). Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am. J. Respir. Crit. Care Med., 161, 1881-1886.
20. LEFF, A.R. (2000). Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am. J. Respir. Crit. Care Med., 161, S125-S132.
21. LIN, A.H., MORTON, D.R. & GORMAN, R.R. (1982). Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes. J. Clin. Invest., 70, 1058-1065.
22. LIU, Y., COUSIN, J.M., HUGHES, J., VAN DAMME, J., SECKL, J.R., HASLETT, C., DRANSFIELD, I., SAVILL, J. & ROSSI, A.G. (1999). Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol., 162, 3639-3646.
23. MARTIN, M.C., DRANSFIELD, I., HASLETT, C. & ROSSI, A.G. (2001). Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem., 276, 45041-45050.
24. MEAGHER, L.C., COUSIN, J.M., SECKL, J.R. & HASLETT, C. (1996). Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol., 156, 4422-4428.
25. 2. J. Leukoc. Biol., 52, 269-273.
26. MECKLENBURGH, K., MURRAY, J., BRAZIL, T., WARD, C., ROSSI, A.G. & CHILVERS, E.R. (1999). Role of neutrophil apoptosis in the resolution of pulmonary inflammation. Monaldi Arch. Chest Dis., 54, 345-349.
27. MURRAY, J., BARBARA, J.A.J., DUNKLEY, S.A., LOPEZ, A.F., VAN OSTADE, X., CONDLIFFE, A.M., DRANSFIELD, I., HASLETT, C. & CHILVERS, E.R. (1997). Regulation of neutrophil apoptosis by tumor necrosis factor-α: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood, 90, 2772-2783.
28. O'FLAHERTY, J.T. & ROSSI, A.G. (1993). 5-Hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J. Biol. Chem., 268, 14708-14714.
29. ROSSI, A.G., COUSIN, J.M., DRANSFIELD, I., LAWSON, M.F., CHILVERS, E.R. & HASLETT, C. (1995). Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Commun., 217, 892-899.
30. ROSSI, A.G. & HASLETT, C. (1998). Inflammation, cell injury and apoptosis. In: Lung Biology in Health and Disease. ed. Lenfant, C. pp. 9-24. New York: Marcel-Dekker.
31. ROSSI, A.G., HASLETT, C., HIRANI, N., GREENING, A.P., RAHMAN, I., METZ, C.N., BUCALA, R. & DONNELLY, S.C. (1998). Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J. Clin. Invest., 101, 2869-2974.
32. 4 and platelet-activating factor: an ultrastructural and pharmacological study. J. Leukoc. Biol., 53, 117-125.
33. SAMUELSSON, B., DAHLEN, S.E., LINDGREN, J.A., ROUZER, C.A. & SERHAN, C.N. (1987). Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science, 237, 1171-1176.
34. SAVILL, J.S., WYLLIE, A.H., HENSON, J.E., WALPORT, M.J., HENSON, P.M. & HASLETT, C. (1989). Macrophage phagocytosis of ageing neutrophils in inflammation. Programmed cell death in the neutrophil leads to recognition by macrophages. J. Clin. Invest. 83, 865-875.
35. 4 receptors. J. Exp. Med., 192, F5.
36. 4 receptor antagonist CP-105696. J. Pharmacol. Exp. Ther., 273, 176-184.
37. 4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. J. Immunol., 168, 3570-3576.
38. STERN, M., MEAGHER, L., SAVILL, J. & HASLETT, C. (1992). Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol., 148, 3543-3549.
39. STERN, M., SAVILL, J. & HASLETT, C. (1996). Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by αvβ3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am. J. Pathol., 149, 911-921.
40. TAYLOR, E.L., MEGSON, I.L., HASLETT, C. & ROSSI, A.G. (2001). Dissociation of DNA fragmentation from other hallmarks of apoptosis in nitric oxide-treated neutrophils: differences between individual nitric oxide donor drugs. Biochem. Biophys. Res. Commun., 289, 1229-1236.
41. TAYLOR, E.L., MEGSON, I.L., HASLETT, C. & ROSSI, A.G. (2003). Nitric oxide; a key regulator of inflammatory cell apoptosis. Cell Death Differ, 10, 418-430.
42. WALSH, G.M., SEXTON, D.W., BLAYLOCK, M.G. & CONVERY, C.M. (1999). Resting and cytokine-stimulated human small airway epithelial cells recognize and engulf apoptotic eosinophils. Blood, 94, 2827-2835.
43. WALSH, G.M., WILLIAMSON, M.L., SYMON, F.A., WILLARS, G.B. & WARDLAW, A.J. (1996). Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood, 87, 2815-2821.
44. WARD, C., CHILVERS, E.R., LAWSON, M.F., PRYDE, J.G., FUJIHARA, S., FARROW, S.N., HASLETT, C. & ROSSI, A.G. (1999a). NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem., 274, 4309-4319.
45. WARD, C., DRANSFIELD, I., CHILVERS, E.R., HASLETT, C. & ROSSI, A.G. (1999b). Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol. Sci., 20, 503-509.
46. 2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of IκBα degradation using a peroxisome proliferator-activated receptor-γ-independent mechanism. J. Immunol., 168, 6232-6243.
47. WARD, C., WONG, T.H., MURRAY, J., RAHMAN, I., HASLETT, C., CHILVERS, E.R. & ROSSI, A.G. (2000). Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism. Biochem. Pharmacol., 59, 305-314.
48. WHYTE, M.K.B., MEAGHER, L.C., HARDWICK, S., SAVILL, J.S. & HASLETT, C. (1993a). Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro. J. Clin. Invest., 92, 446-455.
49. WHYTE, M.K.B., MEAGHER, L.C., MACDERMOT, J. & HASLETT, C. (1993b). Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol., 150, 5123-5134.
50. YOKOMIZO, T., IZUMI, T., CHANG, K., TAKUWA, Y. & SHIMIZU, T. (1997). A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature, 387, 620-624.
51. 4 receptor, BLT2: a new therapeutic target in inflammation and immunological disorders. J. Exp. Med., 192, 421-432.
52. YU, K., BAYONA W, KALLEN, C.B. HARDING, H.P., RAVERA, C.P., MCMAHON, G., BROWN, M. & LAZAR, M.A. (1995). Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem., 270, 23975-23983.